Search results
Moderna’s First Vaccine Was a Big Hit. Its Second Is a Let Down
Bloomberg via Yahoo Finance· 7 hours ago(Bloomberg) -- Moderna Inc.’s pioneering Covid shot turned the company into a nearly $200 billion...
If You'd Invested $1,000 in Moderna Stock 5 Years Ago, Here's How Much You'd Have Today
Motley Fool via Yahoo Finance· 4 hours agoFive years ago, pharmaceutical company Moderna (NASDAQ: MRNA) was mostly unknown. It was developing...
Positive week for Moderna, Inc. (NASDAQ:MRNA) institutional investors who lost 6.8% over the past...
Simply Wall St. via Yahoo Finance· 5 hours agoKey Insights Significantly high institutional ownership implies Moderna's stock price is sensitive...
Metis Global Partners LLC Trims Stock Position in Moderna, Inc. (NASDAQ:MRNA)
ETF DAILY NEWS· 10 hours agoMetis Global Partners LLC reduced its stake in shares of Moderna, Inc. (NASDAQ:MRNA – Free Report) by 19.9% during the fourth quarter, according to the company in its most ...
Moderna’s mRNA Dreams Meet Reality With First Post-Covid Shot
Bloomberg· 7 hours agoThe biotech’s lackluster new RSV vaccine undercuts the promise of mRNA to revolutionize health care....
Moderna’s Promise of mRNA Undercut by New RSV Vaccine
Bloomberg· 2 hours agoConnecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly...
Is Moderna Stock A Buy On Its Eye-Popping First-Quarter Sales Beat?
Investor's Business Daily· 1 day agoModerna stock broke out for the first time in over a year on May 2 after the biotech company notched...
Sisk selected for MITC fit-out in Oxfordshire
World Construction Network via Yahoo Finance· 4 hours agoConstruction and engineering company Sisk has been selected as the preferred bidder for the fit-out of Moderna’s new drug substance and manufacturing...
Moderna Breaks Out For The First Time In A Year After Covid Shot Wallops Sales Views
Investor's Business Daily· 7 days agoModerna stock broke out for the first time in a year on Thursday after beating Wall Street's...
Moderna Reports Smaller Than Expected Q1 Loss, Prepares For RSV Vaccine And Spikevax 2024-2025...
Benzinga via Yahoo Finance· 7 days agoThursday, Moderna Inc (NASDAQ:MRNA) reported a first-quarter EPS loss of $(3.07), down from an...